Only transesophageal echocardiography guided patent foramen ovale closure: A single-center experience
Open Access
- 11 October 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 9, 977959
Abstract
Background: An increasing number of studies have proved that patent foramen ovale (PFO) occlusion could reduce the incidence of recurrent stroke more than drug therapy alone under certain conditions. Which is the “best” guidance technique still remains to be discussed.Methods: A single center retrospective study enrolled 120 patients (mean age 52.51 ± 14.29 years) who underwent PFO closure between April 2019 and March 2021. 87 patients (72.5%) had suffered cryptogenic stroke (CS) at least one time, and 24 patients (20%) had repetitive episodes of hemicrania unsourced. 65 patients were in the transesophageal echocardiography (TEE) guidance group (T-group), and the other 55 patients were in the angiographic guidance group (A-group).Results: There were no significant differences in crucial clinical characteristics between the two groups. In T-group, the procedural success rate was higher (100% vs. 92.7%, P = 0.028), and the procedural time was shorter (23.15 ± 13.87 vs. 25.75 ± 7.19, P = 0.001). No difference was detected in the procedural complication rate. Follow-up were performed at least 12 months. At 12 months, new atrial fibrillation occurred in 1 patient (1.5%) in the T-group and in 1 patient (1.8%) in the A-group (P = 0.905). Residual shunt occurred in 1 patient (1.5%) in the T-group and in 3 patients (5.5%) in the A-group (P = 0.236). Recurrent cerebral ischemia occurred in 2 patient (3.1%) in the T-group and in 2 patients (3.6%) in the A-group (P = 0.865).Conclusion: The use of only intra-procedural TEE guidance for PFO closure is safe and effective. The whole procedure can be performed without fluoroscopy and contrast medium. The short and medium follow-up results are satisfactory, especially in the residual shunt.Keywords
This publication has 24 references indexed in Scilit:
- Effective Bolus Dose of Sufentanil to Attenuate Cardiovascular Responses in Laryngoscopic Double-Lumen Endobronchial IntubationAnesthesiology and Pain Medicine, 2016
- PFO closure with only fluoroscopic guidance: 7 years real‐world single centre experienceCatheterization and Cardiovascular Interventions, 2014
- Cryptogenic Stroke: How to Define It? How to Treat It?Current Cardiology Reports, 2013
- Percutaneous Closure of Patent Foramen Ovale in Cryptogenic EmbolismNew England Journal of Medicine, 2013
- Contemporary echocardiographic guiding tools for device closure of interatrial communications2013
- The role of echocardiography in diagnosis, monitoring closure and post-procedural assessment of patent foramen ovaleEuropean Heart Journal - Cardiovascular Imaging, 2010
- Echocardiographic Evaluation of Patent Foramen Ovale Prior to Device ClosureJACC: Cardiovascular Imaging, 2010
- Safety and feasibility of percutaneous closure of patent foramen ovale without intra-procedural echocardiography in 825 patients.2008
- Patent Foramen Ovale and Cryptogenic Stroke in Older PatientsNew England Journal of Medicine, 2007
- Detection of Right-to-Left Shunt with Ultrasound Contrast Agent and Transcranial Doppler SonographyCerebrovascular Diseases, 2000